Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation
Company Logo

Destroying Cancer at the Speed of Light®

Clinical Study Underway (75 of 100 Patients Treated)
Expected to complete enrollment in 2025
Expected to complete study at the end of 2026


Bullboard - Investor Discussion Forum Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called... see more

TSXV:TLT - Post Discussion

View:
Post by DJDawg on Aug 12, 2024 5:50pm

Finances

Can someone who reads finances better that I, comment on the cash situation? How long to run out again?
Comment by O12009 on Aug 12, 2024 8:00pm
Hoping they can make it to BTD so the next raise could be more favourable terms.  If they were able to get BTD or pre BTD before the next update on Aug 21 then a major part of the Aug 22 warrants could be exercised which would bring in enough money to settle the financial situation and start new Phase 1 trials for GBM and lung cancer. hoping for the best 
Comment by DJDawg on Aug 12, 2024 9:17pm
How do we know that there is an update on Aug 21?
Comment by Yajne on Aug 12, 2024 10:05pm
Dawg, second paragraph of todays NR: Theralase® will be hosting a conference call on Wednesday August 21st, 2024 at 11:00 am ET, which will include a presentation of the financial and operational results for the six-month period ended June 30, 2024. Questions are welcome.
Comment by DJDawg on Aug 12, 2024 10:11pm
Got it. Thanks Y. 11am is during trading hours so that means no new news during that presentation. Oh well. Maybe they will suprise us all with something at some point.
Comment by Yajne on Aug 12, 2024 10:23pm
What are the chances that they can get the pre-BTD in during the next 8 days and NR before 21st? That is a real long-shot, but not impossible. Now THAT would make for a blockbuster conference call....but I'm not holding my breath. They must be fairly close to submitting pre-BTD though to say in todays's NR that they plan to file the pre-BTD and the formal BTD submission to FDA during Q3 ...more  
Comment by Legit62 on Aug 13, 2024 5:33am
That was absolutely the most important statement in the NR, 3rd  quarter, but then again we have heard that before but im feeling this time it may be different, some had mentioned we might have reapplied pre BTD, could be the case and that was what they were waiting for so they got the recent results to the FDA
Comment by DeathXray33 on Aug 13, 2024 6:17am
I'll still be a buyer @ $5.00 +.
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.


Connect with V.TLT



Investor Presentation

View the Presentation

FACT SHEET

View the Presentation

The Watchlist

The Watchlist
{{currentVideo.videoCaption}}
< Previous Video {{moreVideoText}} Next Video >

Investment Opportunity

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 75 of 100 Patients Treated (Enrollment to be completed in 2025, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

Facebook

Contact Us

Address:
41 Hollinger Road
Toronto, ON M4B 3G4
Canada

Toll Free:
1-866-THE-LASE (843-5273)
Local Phone:
416-699-LASE (5273)

Email:
info@theralase.com

Fax:
416-699-5250